Stage II Breast Cancer Completed Phase 1 / 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00470301Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerTreatment